TrialSpark Rebrands as Formation Bio, Continuing Its Commitment to Advancing Drug Development Innovation.

Benjamine Liu, Formation Bio's co-founder and CEO shared more about the change, "Our decision to rebrand as Formation Bio is a significant milestone in our journey to redefine the way new treatments are developed and delivered to patients. Over the past few years, we have operated as a clinical stage pharmaceutical company, growing our drug pipeline and advancing our in-house drug development capabilities. Now, our brand reflects that identity. We are seeing a strong appetite among large pharma and biotech companies alike to partner with us to advance promising therapies, especially as they discover more drugs than they have the resources to advance themselves."

The new name - Formation Bio - embodies a number of relevant motifs. "We formulate new treatments. We form new types of teams, technology, and operational processes," explained Lily Mintz, Formation Bio's Director of Brand Strategy and Communications. "The name will anchor us as we grow, staying the course through every stage of innovation as we form the pharma company of the future."

LINKS
- https://www.formation.bio/

IMDaily is brought to you by https://MyPodcast.Media
Hosted by Shawn P Neal

10x your brand storytelling power with MyPodcast.Media


#businessgrowth #shawnpneal #mypodcastmedia #yourcustomersarelistening #DisruptWithPodcasting #rebrand #pharma